Single-chain antibodies, synthesized by the cell and targeted to a par
ticular cellular compartment, can be used to interfere in a highly spe
cific manner with cell growth and metabolism. Recent applications of t
his technology include the phenotypic knockout of growth-factor recept
ors, the functional inactivation of p21(ras) and the inhibition of HIV
-1 replication. Intracellular antibodies are likely to have a widespre
ad impact in biological research as a simple and effective alternative
to other forms of gene inactivation; they demonstrate clear potential
as reagents for cancer therapy and for the control of infectious dise
ases.